Ann: Syd Capital Markets Briefing Presentation, page-13

“biotechs/medical stocks is often a long game.”

Yes I don’t think early investors would have been expecting things to happen overnight but 3-4 decades later, to still be going through P2 trials for an obvious indication like NSV is fkg insane.

Big pharma has gotten literal poisons approved (without being locked into draconian centres -even showing little to no efficacy) in a third of the time it’s taken for scenesse to be lock down “special centre” approved and completely ignored.

Makes it all the more confusing and concerning to me as to why they didn’t put in the hard work needed , while attempting everything humanly possible to fully exploit the one small opportunity eventually given by EU , US regulators (through clenched teeth), especially when he knew exactly how much the regulator disapproved of the (big toxic suncream industry busting) skin tanning drug.